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ARTICLE
Single-molecule kinetics of pore assembly by the
membrane attack complex
Edward S. Parsons1, George J. Stanley1, Alice L.B. Pyne 1, Adrian W. Hodel1,2, Adrian P. Nievergelt 3,
Anaïs Menny4, Alexander R. Yon1,2, Ashlea Rowley5, Ralf P. Richter5,6,7, Georg E. Fantner 3,
Doryen Bubeck 4 & Bart W. Hoogenboom 1,2,8
The membrane attack complex (MAC) is a hetero-oligomeric protein assembly that kills
pathogens by perforating their cell envelopes. The MAC is formed by sequential assembly of
soluble complement proteins C5b, C6, C7, C8 and C9, but little is known about the rate-
limiting steps in this process. Here, we use rapid atomic force microscopy (AFM) imaging to
show that MAC proteins oligomerize within the membrane, unlike structurally homologous
bacterial pore-forming toxins. C5b-7 interacts with the lipid bilayer prior to recruiting C8. We
discover that incorporation of the ﬁrst C9 is the kinetic bottleneck of MAC formation, after
which rapid C9 oligomerization completes the pore. This deﬁnes the kinetic basis for MAC
assembly and provides insight into how human cells are protected from bystander damage by
the cell surface receptor CD59, which is offered a maximum temporal window to halt the
assembly at the point of C9 insertion.
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he formation of lethal membrane pores is a ubiquitous
event in defence and attack between pathogens and their
hosts1–3. It plays a critical role in the lytic, antimicrobial
activity of human serum, the discovery of which was an early
milestone in immunology4, and decades of study have unravelled
the interplay between proteins that lead to the formation of
immune pores in microbial membranes. The formation of these
membrane attack complex (MAC) pores represents the ﬁnal step
in the activation of the complement system, an integral compo-
nent of innate immunity, which surveys our body for pathogenic
bacteria and which ‘complements’ the ability of leukocytes to kill
pathogens. Dysregulation of MAC formation has been implicated
in human disease5,6, and therapeutics that control complement
are being harnessed for cancer immunotherapy7,8. Understanding
how complement proteins assemble from innocuous soluble
monomers into killer transmembrane pores can therefore con-
tribute to developing strategies for treating human disease where
the MAC is implicated5, and for repurposing the complement
system as a potent immunotherapeutic9.
Assembly of the MAC is the end product of a complex series of
biochemical interactions in which initially soluble complement
proteins bind and undergo dramatic structural rearrangements to
form a transmembrane pore. The resulting MAC pore is a hetero-
oligomer formed from the irreversible, stepwise assembly of 7
different polypeptide chains: C5b, C6, C7, C8 (a hetero-trimer
comprised of C8α, C8β and C8γ) and C9, where 18 copies of C9
are required to complete the pore (Fig. 1a, inset, Supplementary
Fig. 1). Triggered upon detection of a pathogen, activation of
complement leads to the generation of C5b via the cleavage of C5
by membrane-bound C5-convertase enzymes10. C5b is a meta-
stable intermediate that rapidly sequesters C611. Recruitment of
C7 unfurls a lipophilic domain upon binding, while integration of
C8 into the assembly is accompanied by an initial insertion into
the membrane. The C5b-8 initiator complex then binds C9 and
undergoes unidirectional, clockwise oligomerization (with 18
copies of C9) to complete an 11 nm wide transmembrane pore, as
characterised in increasing structural detail by cryo-electron
microscopy (cryoEM)12–16. Together with crystallographic
structures of component proteins, high-resolution cryoEM ana-
lyses of the full pore have identiﬁed regulatory roles for auxiliary
domains15,17,18 that control the transition from stable proteins in
our blood to lethal transmembrane pores. However, it remains
unclear which are the rate-limiting steps in the assembly pathway
of these complement proteins.
As there is no known lipid or receptor speciﬁcity for MAC
membrane insertion, the kinetics of pore assembly drives both the
rapid innate immune response to pathogens and dictates how the
MAC can be most effectively inhibited on membranes of self-
cells. For human cells, the only known membrane-associated
inhibitor of MAC assembly is CD59, a glycosylpho-
sphatidylinositol (GPI) anchored cell surface receptor. CD59
binds the transmembrane residues of C8 and C919, preventing
pore formation and further oligomerization of C920. The kinetics
of MAC formation must allow a temporal window such that
inhibitory factors can interfere at appropriate stages in the
assembly pathway. Therefore, a kinetic analysis of MAC assembly
will provide a much-needed framework to understand how CD59
inhibits lysis.
To understand the molecular mechanism and kinetics under-
pinning how and when the MAC assembly becomes cytolytic, we
sought to track the progression of the complement terminal
pathway at the level of single pores. Using rapid atomic force
microscopy (AFM) imaging on supported model membranes, we
visualize the initial interactions of complement proteins with the
membrane, and resolve the kinetics of MAC pore formation.
Together these data reveal the overall rate of the assembly process
and identify which steps in the pathway are rate-limiting.
Results
MAC forms pores in bacterial model membranes. To enable
AFM tracking of MAC self-assembly at single-molecule resolu-
tion, we developed a model membrane system that supported the
formation of transmembrane pores. We sequentially incubated
complement proteins C5b6, C7, C8 and C9 at physiological
concentrations10,21 on supported bilayers formed from E. coli
lipid extract22 and from pseudo E. coli lipid mixtures comprised
of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dio-
leoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG) and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). In our
model comprised of synthetic lipids, we sought to harness the
physico-chemical properties of the bacterial membrane: PG lipids
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Fig. 1 Formation of MAC on bacterial model membranes. a 3D AFM representation of the endpoint MAC pore structure on supported bilayers composed of
an E. coli lipid extract. Inset: Schematic of the MAC, self-assembled from complement proteins C5b6, C7, C8 and C9, embedded within a lipid membrane.
b Zoom-in of a single MAC pore (marked with an asterisk in a). c Negative-stain EM of E. coli lipid bilayers deposited on silicon dioxide grids, sequentially
incubated with complement proteins C5b6, C7, C8 and C9, resulting in characteristic MAC rings observed in the bilayer membrane. Scale bars: a, c 50 nm,
b 25 nm. Height scale (scale inset in b), a, b 20 nm
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harbour negative charge in their phosphoglycerol headgroup,
whilst PE introduces a degree of stored curvature elastic stress
into the plane of the membrane23. Inspection by AFM and
ﬂuorescence recovery after photobleaching (FRAP) reveals a
single continuous supported bilayer with rapid in-plane diffusion
(Supplementary Fig. 2).
High-resolution AFM images of the resulting end-point MAC
pores are consistent with cryo-EM reconstructions (Supplemen-
tary Fig. 3a–d). We clearly resolve the lumen of the β-barrel pore
in addition to the protruding C5b stalk that hallmarks the MAC
(Fig. 1, Supplementary Fig. 1)12–16. Vesicle lysis assays corrobo-
rate the functional requirement of both a C5b-8 ‘initiator’ and C9
‘propagators’ for MAC to form lytic pores (Supplementary
Fig. 3e); and negative-stain EM on lipid bilayers shows that C5b-8
is required for the oligomerization and insertion of C9 within
the membrane (Supplementary Fig. 4). Together, these data
conﬁrm that the C5b-8 initiator complex, comprised of C5b6 in
complex with C7 and C8, is essential for the formation of a
functional MAC within the bacterial model membrane. Finally,
we veriﬁed that an equivalent degree of MAC formation was
observed across the lipid compositions used in this work
(Supplementary Fig. 5).
C5b-7 initiates MAC assembly on the target membrane. Pre-
vious biochemical studies of MAC formation were performed on
an ensemble of erythrocyte and liposome membranes, preventing
analysis of individual pores24–26. By contrast, our experimental
system facilitates a stepwise study of MAC assembly at the single-
molecule level. Upon addition of C5b6 to a bacterial model
membrane, we observe features of few-nanometre dimensions
(Fig. 2a, Supplementary Fig. 6). Their transient nature on the
membrane and protruding structure pose a challenge for AFM
imaging27,28, in practice putting them at the detection limit of
AFM. At higher sampling rates (Supplementary Movie 1), AFM
force sensitivity was sacriﬁced for enhanced speed of imaging – in
these instances, early assemblies are more difﬁcult to detect.
Further in situ incubation with C7 yields an increase in the
number of such features, which appear with enhanced clarity
after the addition of C8 (Fig. 2a, Supplementary Fig. 6). These
data indicate that C5b6 interacts with the bacterial model
membrane and becomes more resistant to the movement of the
scanning AFM tip following assembly with C7 and C8.
To rule out artefacts due to the inherent invasiveness of the
AFM measurement, we also performed binding assays by quartz
crystal microbalance with dissipation monitoring (QCM-D) to
study the protein assembly on/in membranes29–32, which
correlate with our AFM data. Brieﬂy, we prepared supported
lipid bilayers on silicon dioxide coated QCM-D sensors, with
which we could detect membrane binding of complement
proteins31,32 (Fig. 2b, Supplementary Fig 7). Upon addition of
C5b6, we observe shifts in frequency (Δf) and dissipation (ΔD)
with large variability between samples. Incubations with C5b-7
followed by C8 show consistently strong responses as stable
complexes bind to the membrane and could not be removed by
washing with excess buffer. From the analysis of the binding
kinetics, and the C5b-7 dose-dependent C8 and C9 binding
response, we show that the stoichiometry of the complex is
determined by C5b-7 binding (Supplementary Fig. 8a). The
QCM-D data also reveal that the protein complex becomes
mechanically less compliant by its insertion into the membrane
upon addition of C8 and C9 (Supplementary Fig. 8b)33. Upon
addition of C9, we observe a ﬁnal shift in frequency,
corresponding to the inserted MAC pore. Taken together, these
results demonstrate that the MAC is initiated by C5b6, which is
explicitly required for C7 to bind to the membrane and propagate
pore formation.
C9 monomers are recruited directly from solution. MAC pro-
teins are structurally homologous to the immune protein perforin
and to bacterial cholesterol dependent cytolysins, both of which
form pores through the homo-oligomerization of membrane-
associated monomers3,27–30,34–37. We next explored whether the
hetero-oligomeric MAC pore could assemble via analogous
membrane-bound C9 oligomers, prior to its association with
C5b-8. However, from the absence of C9 on E. coli lipid bilayers
in the electron microscopy and AFM images in Supplementary
Fig. 5, we conclude that such intermediates, if existing at all, are
only transiently bound to the membrane. Upon addition of C9,
AFM imaging (Supplementary Movie 1) does not show the
characteristic pre-pore carpet that was detected by AFM for
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Fig. 2 C5b-7 initiates MAC formation and recruits C8 and C9 directly from solution. Binding of complement components C5b6, C7 and C8 to supported
bacterial model membranes containing PG lipids, as observed by AFM and QCM-D. a AFM images increasingly show protruding features upon addition of
C5b6, C7 and C8 to a bilayer formed of DOPE:DOPG (50:50mol%). Scale bar: 200 nm, height scale: 1 nm. b QCM-D binding assay following the addition
of complement proteins, in reverse sequence followed by the forward sequence, to a lipid bilayer formed of DOPC:DOPE:DOPG (47.5:47.5:5 mol%) on a
silicon dioxide coated QCM-D sensor. In isolation, complement proteins C7, C8 and C9 do not bind to the membrane, requiring C5b6 to initiate the
interaction. Distinct steps in both frequency (Δf) and dissipation (ΔD) upon sequential addition of C5b-7, C8 and C9 demonstrate protein binding to the
membrane; wash steps (denoted by dotted red lines) between additions do not lead to a reduction in the signal size, revealing that the protein binding is
stable. The dissipation shift increases upon binding, reﬂecting the relative softness of the protein complexes in the lipid bilayer ﬁlm
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perforin27 and the cholesterol dependent cytolysin suilysin28.
Instead, we observe a planar membrane background that remains
featureless until MAC pores emerge, implying the absence of any
pre-pore oligomers until the pore is assembled within the
membrane. The static nature of these MACs conﬁrms their
membrane-inserted, pore character27. To further validate that C9
binds directly to C5b-8 and does not form C9 pre-pores on the
membrane, we performed QCM-D analysis of bilayers that were
incubated with complement proteins in the reverse order (i.e. C9,
C8, C7, C5b6, Fig. 2b), with wash steps in between. C9, C8 and
C7 separately did not show any signiﬁcant binding to the
membrane in the absence of other proteins. Taken together, these
data demonstrate that C9 monomers are recruited directly from
solution to the nascent pore and not via a membrane-bound C9
intermediate.
Initial C9 insertion is a kinetic bottleneck in MAC assembly.
By tracking the appearance and evolution of individual pores, we
next determined the reaction kinetics that govern MAC assembly.
Upon association with C5b-8, C9 oligomerizes to complete a
transmembrane pore. With a frame rate of 6.5 s per frame, we
used AFM to visualise C9 oligomerization in real time at 30 °C
(Fig. 3a, Supplementary Movie 1, in which t= 0 is deﬁned as the
time of C9 addition); data recorded at the physiological 37 °C
showed similar kinetics (Supplementary Fig. 9, Supplementary
Movie 2). A single MAC pore is formed within the ﬁrst few
frames, immediately after addition of C9. The pore persists in
isolation for 30 s, after which multiple (3–5) pores appear
simultaneously, and the number of pores augments at a gradually
decreasing rate, up to ~50 MAC pores in the ﬁeld of view at the
end of the recording (Supplementary Movie 1 and Fig. 3).
Remarkably, complete MAC pores continue to appear over an
hour; yet the completion of each individual MAC occurs at the
timescale of seconds to minutes (Fig. 3a, Supplementary Movie 1).
Hence, two distinct kinetic steps are observed upon C9 addition
to the nascent MAC. Firstly, we observe slow C9 binding to C5b-
8, which is taken as our initial detection of a pore-forming event
after the addition of C9. We deﬁne kinetics of this event by a
characteristic initiation time τinit. Secondly, our data show rapid
C9 oligomerization to a C5b-8C9n MAC pore. We deﬁne the time
for each growing pore to fully assemble as τolig. Consistent with
the description of these two distinct kinetic steps, the vast
majority of end-point MACs in our data are complete, ring-
shaped pores. If the rate of initial C9 insertion were faster than
the subsequent oligomerization reaction, kinetically trapped, arc-
shaped assemblies would occur due to monomer depletion, as has
been observed for other pore-forming proteins27,28,34. To
determine whether the kinetic bottleneck is attributed to C8
incorporation or insertion of the ﬁrst C9, we allowed an extended
temporal window after the addition of C8 and prior to adding C9:
we conﬁrm by time-lapse AFM imaging that this does not lead to
more efﬁcient/faster MAC formation (Supplementary Fig. 10,
Supplementary Movie 3).
Rapid AFM imaging allows quantiﬁcation of reaction times. To
quantify the reaction time of initiation and oligomerization, we
analysed rapid AFM imaging data of pore assembly. Considering
the up to 100-fold difference between the timescales of MAC
appearance (initiation) and completion (C9 oligomerisation), the
timescale of completion can be assumed negligible relative to that
of initiation. We detected pores by cross-correlation during
particle tracking (see methods), and take pore appearance as a
proxy that reports on the time of initiation of MAC assembly
after addition of C9 to the reservoir. In doing so, we determine a
characteristic initiation time τinit= 912 ± 32 s (Fig. 3b).
The kinetics of C9 oligomerization were determined by
tracking areas with individual pores from just before the point
of initial detection to after completion (Fig. 4, Supplementary
Movie 4). Image sequences of these tracks show distinct
intermediates of a growing pore as the MAC completes (Fig. 4a,
Supplementary Fig. 11). To quantify the timescale of the
transition we use the average frame height (deﬁned by the
average pixel intensity) as a proxy to report on the completeness
of the pore. As the pore evolves we observe a gradual increase in
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Fig. 3 AFM shows that initial insertion of C9 is rate limiting in MAC assembly. a Time-lapse AFM imaging of MAC assembly on supported bilayers formed
of E. coli lipid extract (see Supplementary Movie 1 for full data set). MAC assembly events initiate at distinct time points, with each MAC pore rapidly
completing within a few frames; this implies a rate-limiting-step corresponding to initial insertion of C9. Scale bar: 200 nm; height scale (colour scale bar
inset in image for t= 0min): 40 nm. b Number of MAC assemblies detected (see Methods) with time, indicated as grey squares; the solid red line
represents ﬁtting with the function A(1–exp(–t/τinit)), where τinit= 912 ± 32s represents the characteristic time of MAC pore appearance, highlighted by the
dashed green lines. The completion time of each individual MAC is much shorter than τinit
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the average height in the frame, which plateaus as the MAC
reaches a ﬁnal state (Fig. 4b, Supplementary Figs. 11–12,
Supplementary Movie 4). Previous structural studies deﬁned the
stoichiometry of the complete MAC as having 18 copies of C912.
To measure the time required to add 17 copies of C9 after the
initiation event, τolig, we record the width of the transition
between detection of the initial event and appearance of a
complete MAC pore, τolig= 112 ± 17 s (Fig. 4c). This is an order
of magnitude shorter than τinit, and implies that the average time
per addition of each of the remaining 17 C9 subunits (τ+= τolig/
17= 6.6 ± 1.0 s) is more than two orders of magnitude shorter
than τinit.
A kinetic model for C9 assembly in the MAC. Given that
τinit  τþ, we can interpret our data in terms of the separate
reactions C5b-8þ C9!
kinit C5b-8ðC9Þ1 and C5b-8ðC9Þn þ
C9!
kþ
C5b-8ðC9Þnþ1 (1  n < 18), with respective rate constants
kinit and k+. We observe that the C9 oligomerization times are
independent of the time at which the reaction is initiated (Supple-
mentary Fig. 13), consistent with C9 being in excess. As such, the
interpretation of this reaction scheme can be further simpliﬁed by
the assumption of an excess and thus approximately constant C9
concentration in solution ([C9] ≈ 1.4 µM) over the duration of our
experiments. Consequently, under our experimental conditions the
ﬁnal number of MAC pores is set by the number of C5b-8 com-
plexes on the membrane. These assumptions lead to the exponential
time dependence of MAC appearance as observed in Fig. 3b, with
kinit ≈ τinit−1[C9]−1= 0.78 s−1mM−1 (see Methods). In addition,
assuming a constant rate of C9 addition after the insertion of the
ﬁrst C9, we ﬁnd k+ ≈ τ+−1[C9]−1= 108 s−1mM−1 (see Methods).
This more quantitative analysis conﬁrms that the initial insertion of
C9, together with its binding to C5b-8, is the major rate-limiting step
in MAC assembly. Interestingly, this rate-limiting step coincides
with the stage where MAC pore formation is inhibited by CD59,
which is present on the surface of human cells to prevent them from
being lysed by complement19,20,38.
Discussion
The MAC represents a biomedically important system in which
to probe how unique individual proteins self-assemble into a
macromolecular functional unit. Once initiated, ﬁve soluble
complement proteins sequentially and irreversibly self-assemble
into a hetero-oligomeric pore that opens up an 11 nm hole in a
ﬂuid lipid bilayer. While there is an extensive (and still expand-
ing) body of structural and functional information documenting
the MAC and its constituent components, the pathway and
kinetics of its assembly have been more difﬁcult to study24. Here
we have presented rapid AFM imaging data that track MAC
assembly at the single-pore level in real-time. Furthermore, we
have derived kinetic models for initiation and oligomerization of
C9 that explain how rate-limiting assembly intermediates can be
captured by our body’s self-defence mechanism to prevent
disease.
Based on the results presented here, we deﬁne a kinetic path-
way of MAC assembly (Fig. 5). C5b6/C5b-7 binds to bacterial
lipids and serves as a platform for coordinating the sequential
assembly of the MAC at the target membrane, recruiting C8.
Downstream, the C5b-8 initiator complex is explicitly required
for membrane insertion of the initial C9 molecules. Our data
reveal that this initiation phase, which relates to the insertion of
the ﬁrst C9, is the rate-limiting step. A rapid oligomerization
phase completes the transmembrane MAC pore, as further copies
of C9 bind and insert into the membrane directly from solution.
Speciﬁcally, the binding of the initial C9 to C5b-8 is characterised
by a rate constant that is more than two orders of magnitude
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Fig. 4 Real-time imaging of C9 oligomerization. a AFM image sequence of MAC assembly, cropped from data shown in Fig. 3 and Supplementary Movie 1.
C9 oligomerization completes within frames shown (104 s, 6.5 s/frame; 0 s is here approximately deﬁned by the frame preceding detection of the growing
MAC). Scale bar: 30 nm, height scale (see colour scale bar in Fig. 1): 16 nm. b The normalised average frame height versus time for a single pore forming
event (corresponding to event shown in a), plotted here as a measure for completion of MAC assembly. The red line represents a sigmoidal ﬁt to the data,
as a generic and mathematically convenient description of a smooth transition between pore absence and pore completion. The C9 oligomerization time is
determined from the width of the transition, highlighted by green dashed lines (see Supplementary Fig. 12 for details). c Distribution of oligomerization
times, extracted from n= 33 isolated pore forming events in 6 independent experiments
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smaller than that for the subsequent binding of C9 to C5b-8C9n
(1 ≤ n < 18), and occurs more slowly than C5b-8 formation.
Since the propagation of C9 oligomerization is so much faster
than the initiation, we predict that there will be a low probability
of incomplete, arc-shaped assemblies that are kinetically trapped
due to monomer depletion. In agreement with this prediction, we
ﬁnd that MAC assembly favours formation of complete, ring-
shaped pores (Fig. 1a), in contrast to kinetically trapped arc pores
observed for other pore-forming proteins27,28,34. In summary, we
show that once activated, the MAC pore rapidly assembles into
complete ring lesions in the target membrane.
By having distinct initiation and propagation stages, C9
assembly in the MAC resembles pore formation of the related
immune protein perforin, where the rate limiting step is the
insertion of a small (membrane-bound but not yet membrane-
inserted) pre-pore assembly, acting as a nucleation site from
which to grow a transmembrane pore27,39. Although we do not
observe any membrane-bound C9 pre-pore assemblies, the C5b-8
initiator complex, together with a C9 molecule yet to undergo its
transmembrane transition, could serve a similar function. Our
data provides evidence that MAC is a growing pore, similar to
perforin. Distinct initiation and propagation stages have also been
proposed for bacterial cholesterol-dependent cytolysins (CDCs),
with the formation of a stable membrane-bound dimer followed
by the addition of further monomers35. However, the CDCs differ
from the MAC and perforin in that they undergo a concerted
oligomeric pre-pore-to-pore transition, after which no further
assembly events have been observed3,28,34. In a bacterial mem-
brane that harbours a dense proteinaceous network of porins10,40,
such a collective pre-pore-to-pore transition is likely to face a
large free energy barrier; instead, a growing pore that directly
recruits individual monomers from solution can act as a jack that
prises open a hole within the porin lattice.
The transition from soluble monomers to a transmembrane β-
barrel pore requires dramatic conformational changes in the
pore-forming domain of complement proteins. The membrane
attack complex-perforin/cholesterol dependent cytolysin
(MACPF/CDC) domain is comprised of a central kinked β-sheet
with two helical sub-regions (TMH; transmembrane hairpins)
that unfurl to form membrane-inserted β-hairpins. This transi-
tion is accompanied by unbending of the central β-sheet and the
displacement of a latch that releases the TMH bundles. For CDCs,
this latch is manifested as a ﬁfth β-strand of the central sheet that
upon pore-formation converts to a helix-turn-helix, enabling
oligomerization36,37. For MACPF-containing complement pro-
teins, the latch remains helical and moves as a unit to release
transmembrane residues13,15. Interestingly, the rate-limiting step
of MAC assembly, as identiﬁed here, coincides with unfurling of
the hairpins of the ﬁrst C9 into the membrane. This can be
related to the recent structural insight that C9 can bind to the
C5b-8 initiator complex before inserting into the membrane;
however, to propagate oligomerization, it requires conformational
changes with the MACPF domain that accompany membrane
insertion15.
Our results show that C5b-7 initiates MAC assembly at the
membrane with subsequent protein components C8 and C9
integrated directly from solution. Upstream, the C5b6 crystal
structure demonstrated that prior to interacting with membrane
lipids, C6 membrane-interacting residues remain in their soluble
helical form17; however, the C5b6 complex has been shown to
associate with lipid bilayers13. The dual behaviour of C5b6 is
reﬂected in the variability in our results (Fig. 2b, Supplementary
Fig. 7), suggesting that interactions are mediated by a combina-
tion membrane defects and electrostatics13. It is conceivable that
C5b6 membrane-binding is dominated by electrostatic interac-
tions of negatively charged lipid headgroups (such as PG lipids
commonly found in Gram-negative bacteria41) with either the
thrombospondin (TS)1 domain of C642 or by its unfurled
membrane interacting β-hairpin13, both of which expose an
interface rich in positive charge. Such lipid headgroup depen-
dence also emerges from studies on MAC binding31,32 and
complement activation on model membranes43. The observed
membrane binding of C5b6 is consistent with recent work on
bacteria10, reporting that the downstream efﬁciency of MAC
formation is greatly enhanced when C5b6 is actively formed by
C5 convertases bound to the bacterial surface. Our results here
provide the rationale for this observation. We propose that nas-
cent C5b6 can, under certain conditions, interact with the bac-
terial membrane upon its generation by the C5 convertase. C7
greatly enhances the membrane-bound stability of the nascent
complex as it unfurls a lipophilic domain, and recruits C8 directly
to the target membrane. This facilitates binding and oligomer-
ization of C9, thus generating the functional pores that kill the
bacterium.
Although the here discussed lipid dependence suggest some
MAC speciﬁcity for bacterial targets, C5b-8-initiator complexes
can deposit and progress to cytolytic pores on host cells if not
properly controlled. Therefore, human cells express CD59 on
their surface, which disrupt MAC assembly from the point of
C5b-8 formation onwards19,20,38,44,45. Speciﬁcally, CD59 interacts
with MAC precursors at two distinct stages. Firstly, CD59 can
bind after incorporation of C8 (C5b-8) and prevent bilayer per-
foration by the C8α chain44. Secondly, CD59 can bind after
addition of C9 (C5b-9) to inhibit further oligomerization and
pore formation44. CD59 inhibits MAC assembly by binding to the
TMH β-hairpin on the leading-face of C8α (residues 334–385)45
C5b6
+C9
Slow Fast
kinit k+
kinit<< k++C7
+C7 +C8
Fig. 5 Schematic of MAC assembly. Upon formation, C5b6 templates the assembly, recruiting C7 and C8 to the nascent MAC. The C5b-7 complex is
irreversibly bound to the membrane. Insertion of the ﬁrst C9 is the rate limiting step in the MAC assembly; once this barrier has been overcome,
subsequent C9 binding/insertion occurs more than two orders of magnitude faster than the initial C9 insertion
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and to a buried 6 amino acid sequence of C9 (residues 366–371)
that is exposed upon binding C5b-838. However, the structural
basis for how CD59 inhibits complement proteins is unclear. It is
not known whether C9 initiates insertion of its hairpin into the
membrane prior to binding CD59 or if CD59 binds C8 and
C9 simultaneously.
Our data highlight a rate-limiting step at the association of C9
with the C5b-8 MAC precursor. This allows a maximum tem-
poral window for the mechanism by which human cells are
protected from autoimmune attack by the MAC: our model
favours a mechanism whereby C9 has not unfurled into the
membrane immediately upon binding C5b-8, allowing CD59 to
inhibit MAC formation. The here reported initiation step would
thus correspond to the insertion of the ﬁrst C9 into the mem-
brane, facilitating fast recruitment of additional C9 to the growing
transmembrane complex. When CD59-mediated inhibition is
overcome by antibody-based drugs such as rituximab that facil-
itate MAC-induced killing of chronic lymphocytic leukaemia B-
cells, cell death follows at the ~100 s time scale7. This is consistent
with the oligomerization kinetics of a single pore observed here
in vitro, suggesting that only few pores are sufﬁcient to lyse a B-
cell.
In summary, we have determined the pathways and kinetics of
assembly for a hetero-oligomeric protein complex by molecular-
scale measurements. These assembly kinetics govern how MAC
kills bacteria and how our body’s self-defence mechanism pre-
vents membrane damage, which may also be relevant for com-
plement dependent cytotoxicity in cancer immunotherapy7.
Finally, we anticipate that our ﬁndings will guide the inter-
pretation of ongoing studies towards an atomistic model of MAC
structure.
Methods
Materials. E. coli lipid extract (total), 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-
sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG) and 1-palmitoyl-2-(dipyrro-
metheneboron diﬂuoride)undecanoyl-sn-glycero-3-phosphocholine (TopFluor®
PC) were purchased from Avanti Polar Lipids (Alabama, USA) as a powder and
stored at −20 °C prior to use. Complement proteins C5b6, C7, C8 and C9 were
purchased as proteins puriﬁed from human serum from CompTech (Texas, USA)
and stored at −80 °C prior to use. For the rapid AFM imaging experiments, lysis
assays, negative-stain EM and FRAP experiments shown here, E.coli lipid extract
was used. For AFM imaging of intermediates, an equimolar mixture of DOPG:
DOPE was used. For QCM-D binding assays, a lipid mixture of DOPC:DOPE:
DOPG (47.5:47.5:5 mol%) was used, as formation of continuous bilayers contain-
ing high molar ratios of charged lipid ( >30 mol%) were not attainable on the
silicon dioxide QCM-D sensors used here46.
Preparation of lipid vesicles. Pure lipids were dissolved in chloroform at 10mg/mL
and mixed in solution to give a lipid mixture at a desired molar ratio. The lipid-in-
chloroform solution was then dried in a glass vial under a stream of nitrogen gas to
give 1 mg of lipid as a thin ﬁlm. The lipid ﬁlm was hydrated in buffer (20mMHEPES,
120mM NaCl, pH 7.4), vortexed and bath sonicated to give a cloudy lipid suspension.
The suspension was then passed through a 50 nm polycarbonate membrane (GE
Healthcare Lifesciences) 15 times to yield a clear suspension of small unilamellar
vesicles (SUVs). All lipid species used had a gel-to-ﬂuid transition below room
temperature, and therefore were assumed to be miscible without heating.
AFM sample preparation. Supported lipid bilayers were formed by injecting 4.5
µL of the SUV suspension to a freshly cleaved mica disk (6 mm diameter) under 18
µL of incubation buffer (20 mM HEPES, 120 mM NaCl, pH 7.4). CaCl2 solution
(2.5 µL, 100 mM in incubation buffer) was added to give a ﬁnal calcium con-
centration of 10 mM; this induces the rupture of the vesicles onto the mica support
over an incubation period of approximately 30 min. Excess vesicles were then
removed from the supernatant by rinsing with 500 µL of incubation buffer, to yield
a uniform bilayer free of adsorbed vesicles (as assessed by AFM imaging). All SUVs
were incubated at room temperature, above their gel-to-ﬂuid transition
temperature.
Endpoint MAC pores were formed by incubating the supported bilayer in a
humid chamber at 37 °C and sequentially adding complement proteins C5b6, C7,
C8 and C9 at 5 min intervals, with a ﬁnal 15 min incubation after the addition of
C9 prior to initiating the AFM experiment. Final concentrations of complement
proteins were ~80 nM for C5b6, C7 and C8 and 1.4 µM for C9. Excess soluble
protein was removed prior to imaging by washing with 5× sample volume (25–50
µL) of buffer.
‘Real-time’ MAC samples were formed in situ within the AFM liquid chamber.
For experiments at 37 °C using a Bruker Dimension FastScan, the complement
proteins were injected directly onto the supported lipid bilayer whilst imaging. For
rapid imaging experiments performed at 30 °C using home-built AFM
instrumentation described previously47, the sample chamber was passivated with
BSA (0.1 mg/mL in incubation buffer) for 15 min and rinsed with 500 µL buffer
prior to loading the sample with the supported lipid bilayer. Complement proteins
were sequentially injected though channels in the sample chamber to the imaging
volume, while scanning and in the absence of wash steps, to give a ﬁnal protein
concentration of 80 nM for C5b6, C7 and C8 and 1.4 µM for C9.
AFM Imaging. AFM imaging was performed in ﬂuid using a Bruker Dimension
FastScan (for time-lapse imaging at 37 °C), a Bruker BioScope Resolve (for imaging
of MAC intermediates) and a home-built instrument with rapid imaging
capabilities47,48 (for rapid imaging at 30 °C). Imaging was generally performed in
off-resonance tapping/fast force-feedback imaging (Bruker’s PeakForce Tapping)
mode where force-distance curves were recorded at either 8 or 32 kHz, with
amplitudes of 10–20 nm. With these frequencies, images could be collected at
5–100 s/frame. Tapping mode of MAC intermediates was performed while scan-
ning bidirectionally (i.e. turn around at the end of each imaging line; no ‘retrace’).
Rapid PeakForce Tapping (with the z scanner driving at 32 kHz) was performed
with largely custom built hardware as described in detail elsewhere47. Importantly,
the AFM head has a sufﬁciently small laser spot to accommodate miniaturised
cantilevers, and the high-speed scanner is ﬂexure-based with a 1.8 µm × 1.8 µm × 2
µm range and ~100 kHz z bandwidth. Fast force–distance based imaging modes
were implemented by sinusoidally modulating the tip-sample distance at a high
rate between 16 and 32 kHz and recording the resulting deﬂection signal with a
signiﬁcantly higher sampling rate (512 kHz). The resulting periodic hydrodynamic
background was recorded slightly above the surface and subtracted from the
deﬂection in real time. The resulting interaction was a sinusoidal force-distance
curve where the maximum force was used for feedback. For practical purposes,
highest-quality data were recorded at 30 °C; and next compared with results
obtained at the physiological 37 °C (see main text).
Commercial FastScan-D cantilevers (Bruker) were used for all experiments,
except for images shown in Fig. 2, which used pre-release Fast Tapping probes
(Bruker; resonance frequency 140 kHz, spring constant 0.3 Nm−1). FastScan-D
cantilevers have a speciﬁed spring constant of 0.25 Nm−1 with a resonance
frequency of 110 kHz in liquid; this exceeds our ramping frequency by at least a
factor of 3, sufﬁcient to avoid coupling between the ramping frequency and the
cantilever resonance. Cantilevers were rinsed in isopropanol:ethanol (1:1) and
plasma cleaned in air prior to use.
AFM data processing. Image analysis was performed using Nanoscope Analysis
version 1.80 (Bruker)27. Brieﬂy, images were plane levelled and line-by-line ﬂat-
tened with the lipid bilayer as a reference. A Gaussian ﬁlter with a full-width half-
maximum of 2 pixels (corresponding to 4 nm) was used to smooth out high
frequency noise where necessary.
Tracking the evolution of a growing pore, and pore counting, was performed as
follows, using MATLAB (MathWorks), and the scripts described were used with
Bruker’s MATLAB toolbox: NSMatlabUtilites.
AFM Movie sequences were loaded into MATLAB, and a 1st order plane
background subtraction was applied to each image. A template pore was user-
selected from the ﬁnal image in the sequence. This was used as the template in a 2D
cross-correlation analysis, applied to each image in the sequence. If features
correlated with the template over a given, normalized threshold value (set as 0.6
here; user-adjusted to optimize recognition), such features were identiﬁed as MAC
pores. The number of features found in each frame was deﬁned as the pore count.
Next, using the coordinates already obtained from the 2D cross-correlation
analysis, the coordinates of the appearance and growth of unique pores were
tracked, and their coordinates stored into a new array (track). This used two
further parameters: (i) A maximum linking distance (typically set at ~30 pixels),
which deﬁnes a pore as being the same unique pore as that detected in the previous
frame, only if the coordinates of the feature were within the maximum linking
distance. (ii) A maximum gap closing (in frames), which deﬁnes the number of
frames in which a feature (that is within the maximum linking distance) cannot be
found and yet is still deﬁned as belonging to the same track (this reduces the risk of
artefacts due to image noise). The pore count and coordinates for individual tracks
were then saved into a data structure.
Next, using the track coordinates, new image sequences for each pore were
cropped to within a radial distance of 25 nm from the centre of the feature, and
including some extra frames recorded before the ﬁrst appearance of a given pore.
For each cropped image sequence, the average height of each frame in the sequence
was calculated and saved into a new array. This analysis was repeated for several
data sets, and the data saved into new data structures. Finally, the cropped image
sequences and average height arrays from several experiments were concatenated.
Each track was inspected by the user and any false positives (caused by having too
small a threshold value for the 2D cross-correlation analysis) were removed. A
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Savitzky-Golay ﬁlter was applied to each remaining average height array to reduce
the effect of image noise. A sigmoid function of the form
f tð Þ ¼ A ´ tanh
t  t0ð Þ
τ
 
þ B ð1Þ
was ﬁtted to each ﬁltered, average height array. A, B, t0, and τ are ﬁtting
parameters, and 3*τ (which corresponds to ~90% of the transition; see
Supplementary Fig. 12) was deﬁned as the width of the transition (and hence
reaction time). If, from the ﬁtting, t0 was negative or 3*τ was longer than the Movie
sequence, this was considered a poor ﬁt and the data was removed. For the image
sequence tracking a single MAC pore in Fig. 4, a 1.5 nm Gaussian ﬁlter was applied.
Pore cross-sectional measurements. Image processing was carried out in
Gwyddion49. Images were plane levelled and line-by-line ﬂattened with the lipid
bilayer as a reference. A Gaussian ﬁlter with a full-width half-maximum of 2 pixels
was used to smooth out high frequency noise. Following this, a cross-section was
then taken diagonally across a single MAC pore (shown in Fig. 1.) and exported.
Data was plotted in Origin.
A MAC pore of structure EM-313412 was imported into Chimera50. Volume
ﬁltering was performed with σ= 14 pixels to obtain a structure with resolution
comparable to that of the AFM data. Given a resolution of 8.5 Å for EM-3134, this
corresponds to a physical width (of the ﬁlter) of 11.9 nm. The volume viewer tool
was optimized to ensure the full surface as shown (level 0.002). The model was then
coloured by height with a black to white gradient (low to high) of −100 to+200 Å
in steps of 75 Å. A top view image was then exported into Gwyddion49 for cross-
sectional analysis. A cross-sectional measurement was taken horizontally across the
pore diameter against the approximate height of a surrounding membrane (50 Å),
including the stalk, and exported. Data was plotted in Origin.
QCM-D measurements. Quartz crystal microbalance with dissipation monitoring
(QCM-D) allows semi-quantiﬁcation of mass deposition to a quartz crystal sensor.
Binding assays were performed by ﬂowing complement proteins over a lipid bilayer
supported by the silicon oxide coated QCM-D sensor. Biomolecules interacting
with the sensor interface give rise to a change in resonance frequency (Δf) and
energy dissipation (ΔD) of the quartz sensor. Brieﬂy, a decrease in resonance
frequency is proportional to an increase in surface-bound mass (where this
includes hydrodynamically coupled solvent in addition to the biomolecules bind-
ing), whilst an increase in dissipation qualitatively correlates with an increase in the
‘softness’ of the ﬁlm33. QCM-D measurements were performed in ﬂow mode at a
ﬂow rate of 10 μL/min using a Q-Sense E4 system equipped with four Q-Sense
Flow Modules (Biolin Scientiﬁc, Vastra Frolunda, Sweden) with a working tem-
perature of 20 °C. Silicon oxide coated QCM-D sensors (QSX 303, Biolin Scientiﬁc)
were used as substrates for supported lipid bilayers. Before injection, C5b6, C7, C8
and C9 were diluted to concentrations of 10, 5, 5 and 50 μg/mL (35, 54, 33 and 704
nM) respectively in incubation buffer (roughly equivalent to half those use in AFM
experiments). Overtones j= 3, 5, 7, 9, 11, and 13 were recorded in addition to the
fundamental resonance frequency (4.95 MHz). Changes in dissipation (ΔD) and
normalised frequency, Δf= Δfj/j, for j= 5 are presented here; all other overtones
provided equivalent information.
Vesicle lysis assays. E. coli lipid extract was suspended at 7.5 mg/mL in calcein
solution (50 mM calcein, 150 mM NaCl, 20 mM Hepes pH 7.4), freeze-thawed 6
times (liquid nitrogen – 65 °C) and extruded through a 100 nm polycarbonate
membrane (Whatman) to form unilamellar calcein-encapsulated liposomes. Non-
encapsulated calcein was removed through liposomes puriﬁcation on a gravity-ﬂow
Sephadex-G50 (GE Healthcare) column (500 mM Sucrose, 150 mM NaCl, 20 mM
Hepes pH 7.4) and liposomes were used immediately. MAC lysis assays of lipo-
somes were performed by sequential addition of C5b6 (5 min, 37 °C), C7 (5 min,
37 °C), C8 and C9 at a mass ratio of 1:1:1:1. In control conditions, identical
volumes of protein buffer (120 mM NaCl, 10 mM Hepes pH 7.4) were added
instead of protein. Self-quenched encapsulated calcein was un-quenched through
its release in the extra-liposomal solution following MAC lesions. Fluorescence was
recorded immediately following C9 addition and every minute for 60 min on a
SpectraMax M2 ﬂuorometer (dual monochromator, ex: 490 nm, em: 520 nm)
(Molecular Devices). Background ﬂuorescence was measured from calcein-
encapsulated liposomes in the absence of protein and subtracted from the data. To
determine the percentage of lysis, the ﬂuorescence was then normalized to the
maximal lysis ﬂuorescence estimated after a freeze-thaw cycle of liposomes incu-
bated in 0.25% sodium dodecyl sulphate (SDS). Fluorescence measures of lysis and
controls were always performed on the same batch of liposomes and in three
independent replicates.
Negative-stain EM. Supported lipid bilayers were formed as described for
equivalent supported lipid bilayers as used in AFM experiments, using 8 nm thick
PELCO® silicon dioxide support ﬁlms for transmission electron microscopy grids
(Agar) as the support instead of mica. Brieﬂy, the glow-discharged grids were
incubated with an SUV suspension in calcium containing incubation buffer (20
mM HEPES, 120 mM NaCl, 10 mM CaCl2), rinsed and incubated with comple-
ment proteins as described above. Importantly, this allowed us to remove all
soluble protein and excess lipid from incubation buffer prior to staining. Samples
grids were rinsed with 500 µl incubation buffer, taking care that they remained
hydrated throughout, and subsequently stained with 2%wt/wt uranyl acetate. The
sample was incubated with uranyl acetate for 60 s and carefully blotted dry,
ensuring that the strain was quickly removed to avoid crystallisation of excess
uranyl acetate at the surface. Samples were imaged on a Tecnai T12 thermionic
ﬁlament microscope (Thermo Fisher Scientiﬁc) at 120 kV. Images were taken with
a defocus of 0.5–1 µm on a Gatan 4 k × 4 k CCD camera, giving a ﬁnal pixel size of
1.64 Å.
Fluorescence recovery after photobleaching. E. coli lipid extract was doped with
0.5 mol% Topﬂuor PC by mixing the respective lipids in chloroform and preparing
SUVs27. A thin mica slide was suspended over a 10mm glass window in a glass
bottomed cell culture plate. Deposition of ﬂuorescently doped SUVs was achieved as
described above, taking care to ensure that the mica support remained hydrated at all
time. Lipid bilayers were transferred to a FV1200 confocal microscope equipped with
a 100 × 1.40 oil immersion objective (both Olympus) and a TC-324B automatic
temperature controller (Warner Instruments) set to 37 °C. The microscope was fur-
ther set to a FV10-LD473 473 nm and 15mW laser diode powered by a FV10-
MCPSU power supply, and the Alexa 488 excitation ﬁlter and BA490–590 emission
ﬁlter sets (all Olympus). The ﬂuorescent bilayers were imaged at 2.5% laser output
power across 49.8 µm wide areas and an acquisition speed of 1.64 s per image. FRAP
was performed on a circular area of 16.4 µm diameter at the centre of an image for 2 s
at a laser output of 80%. Analysis of the FRAP data was performed according to the
Soumpasis model for diffusion limited recovery24,42.
Kinetic analysis. Given that the initiation and prolongation of C9 binding to
C5b-8 occur at such different time scales (τinit and τolig or τ+, respectively),
we approximate the reaction kinetics by considering the separate reactions:
C5b-8þ C9!
kinit C5b-8ðC9Þ1 ð2Þ
and
C5b-8ðC9Þn þ C9!
kþ
C5b-8ðC9Þnþ1 1  n < 18ð Þ; ð3Þ
while assuming an excess (and therefore approximately constant) amount of C9 in
solution (see main text).
The kinetics of the initiation reaction then follows from the differential equation
d C5b-8ðC9Þn
 
=dt ¼ kinit C5b-8½  C9½ ; ð4Þ
where square brackets denote concentrations. For a single C5b-8 complex, we
deﬁne the initiation probability:
pinit  C5b-8ðC9Þ1
 
= C5b-8½  þ C5b-8ðC9Þ1
  
: ð5Þ
This leads to a solution of the form:
pinit ¼ 1 exp kinit C9½ tð Þ: ð6Þ
such that kinit≈τinit−1[C9]−1, with τinit determined as illustrated in Fig. 3b.
Deﬁning
pn  ½C5b-8ðC9Þn=
X18
n¼1
½C5b-8ðC9Þn; ð7Þ
we can describe the subsequent C9 oligomerization via the coupled differential
equations
dp1=dt ¼ kþ C9½ p1 ð8Þ
and
dpn=dt ¼ kþ C9½ pn1  kþ½C9pn ð9Þ
for 2 ≤ n < 18, and dp18/dt= k+[C9]p17.
The average oligomerization rate is given in number of added C9 molecules per
unit of time, as
d nh i=dt ¼
X18
n¼1
n dpn=dt ¼ kþ C9½ 
X18
n¼2
n pn1 
X17
n¼1
n pn
 	
¼ kþ C9½ 
X17
n¼1
ðnþ 1Þpn 
X17
n¼1
n pn
 	
¼ kþ C9½ 
X17
n¼1
pn:
ð10Þ
Taking into account that
P18
n¼1 pn ¼ 1 and assuming that p18 is signiﬁcantly
smaller than 1 (i.e., ignoring the oligomerization of the last few C9s), we ﬁnd a
constant oligomerization rate
d nh i=dt  kþ C9½ ; ð11Þ
such that
kþ  τ
1
þ C9½ 
1; ð12Þ
with τ+ determined as in Fig. 4.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Data availability
Data supporting the ﬁndings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this Article is available as
a Supplementary Information ﬁle. The source data underlying Figs. 2b, 3b, 4b,c and
Supplementary Figs. 2c, 3c–e, 7a–b, 8a–b and 9b are provided as a Source Data ﬁle.
Code availability
Analysis code to extract kinetic parameters from rapid AFM imaging data is available on
github. An example AFM data set is provided as a MATLAB data structure to enable
assessment of the analysis code.
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